Increasing research has focused on exploring the mechanisms responsible for the dysregulation of ALKBH5 in cancers: Hypoxia: ALKBH5 is a direct target of HIF‐1α, indicating that ALKBH5 may be involved in the regulation of cellular responses to hypoxia [169]. This evidence concerns the gene ALKBH5 and cancer.